Summary:
Thyroid dysfunction, a common long-term complication following bone marrow transplantation (BMT), is frequently associated with total body irradiation (TBI) given in the pre-BMT conditioning protocol. We report our preliminary observation of the prevalence of thyroid dysfunction in children transplanted for primary immunodeficiency (PID) who were given cytoreductive conditioning with busulphan and cyclophosphamide, but without TBI. We evaluated thyroid-stimulating hormone (TSH) and free thyroxine (fT4) in 83 survivors transplanted between 1987 and 2002. We found nine children (10.8%) with clinical and/or biochemical thyroid dysfunction at 4 months to 4.5 years post-BMT of which three had positive antithyroid microsomal antibodies. Two patients were classified as primary and seven as compensated hypothyroidism (hyperthyrotropinaemia). Four patients with clinical features of hypothyroidism received replacement thyroxine, while five of the seven patients with compensated hypothyroidism remain off thyroxine because we suspect this may be a transient phenomenon.
Abnormalities of thyroid function including severe primary hypothyroidism may occur post-BMT in children receiving chemotherapy conditioning without TBI. Thyroid function should be assessed regularly in this group of patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Buckley RH . Treatment options for genetically determined immunodeficiency. Lancet 2003; 361: 541–542.
Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003; 361: 553–560.
Gennery AR, Dickinson AM, Brigham K et al. CAMPATH-1M T cell depleted bone marrow transplantation for severe combined immunodeficiency: long term follow up of 19 children treated in the period 1987–1998 in a single centre. Cytotherapy 2001; 3: 221–232.
Slatter MA, Bhattacharya A, Flood TJ et al. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies. Bone Marrow Transplant 2003; 32: 225–229.
Katsanis E, Shapiro RS, Robison LL et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990; 5: 335–340.
Wedderburn LR, Jeffery R, White H et al. Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T and B cell repertoires, and evidence for reversion from the CD45RO+ to RA+ phenotype. Rheumatology 2001; 40: 1299–1307.
Al-Fiar FZ, Colwill R, Lipton JH et al. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant 1997; 19: 1019–1022.
Toubert M-E, Socie G, Gluckman E et al. Short and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preoperative total body irradiation. Br J Haematol 1997; 98: 453–457.
Kami M, Tanaka Y, Chiba S et al. Thyroid function after bone marrow transplantation: possible association between immune-mediated thyrotoxicosis and hypothyroidism. Transplantation 2001; 71: 406–411.
Sherer Y, Shoenfeld Y . Autoimmune diseases and autoimmunity post bone marrow transplantation. Bone Marrow Transplant 1998; 22: 873–881.
Michel G, Socie G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation — a report from the Societe Francaise de greffe de moelle. J Clin Oncol 1997; 15: 2238–2246.
Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087–1092.
Chapel H, Geha R, Rosen F, (IUIS PID classification committee). Primary immunodeficiency disease: an update. Clin Exp Immunol 2003; 132: 9–15.
Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GvHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Gluckberg H, Storb R, Fefer A et al. Clinical manifestations of GvHD in human recipients of marrow from HLA matched sibling donors. Transplant 1974; 18: 295–304.
Tauchmanova L, Selleri C, De Rosa G et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076–1084.
Tunbridge WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481–493.
De Groot LJ . Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metabol 1999; 84: 151–164.
Karthaus M, Gabrysiak T, Brabant G et al. Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells. Bone Marrow Transplant 1997; 20: 697–699.
Devendra D, Eisenbarth GS . Immunologic endocrine disorders. J Allergy Clin Immunol 2003; 111: s624–s636.
Arkwright PD, Abinun M, Cant AJ . Autoimmunity in human primary immunodeficiency diseases. Blood 2002; 99: 2694–2702.
Dupuis-Girrod S, Medioni J, Haddad E et al. Autoimmunity in Wiskott–Aldrich syndrome: risk factors, clinical features, and outcome in a single-centre cohort of 55 patients. Pediatrics 2003; 111: e622–e627.
Schurman SH, Candotti F . Autoimmunity in Wiskott–Aldrich syndrome. Curr Opin Rheumatol 2003; 15: 446–453.
Olivares JL, Ramos FJ, Olive T et al. Autoimmune thyroiditis after bone marrow transplantation in a boy with Wiskott–Aldrich syndrome. J Pediatr Hematol/Oncol 2002; 24: 772–776.
Gambineri E, Torgerson TR, Ochs HD . Immune dysregulation, polyendocrinopathy, enteropathy, and x-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430–435.
Kaino Y, Otoh Y, Tokuda K et al. Acquired hypothyroidism in a very young infant with Omenn's syndrome. J Pediatr 2000; 136: 111–113.
Trendelenburg M, Gregor M, Passweg J et al. ‘Altered immunity syndrome’, a distinct entity in long-term bone marrow transplantation survivors? Bone Marrow Transplant 2001; 28: 1175–1177.
Coles AJ, Wing M, Smith S et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 1995; 354: 1691–1695.
Todd A, Todd J . Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin. Clin Lab Haem 1999; 21: 69–70.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slatter, M., Gennery, A., Cheetham, T. et al. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 33, 949–953 (2004). https://doi.org/10.1038/sj.bmt.1704456
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704456
Keywords
This article is cited by
-
Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases
Bone Marrow Transplantation (2022)
-
Outcome of Non-hematological Autoimmunity After Hematopoietic Cell Transplantation in Children with Primary Immunodeficiency
Journal of Clinical Immunology (2021)
-
Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes
Bone Marrow Transplantation (2018)
-
Single-center analysis of long-term outcome after hematopoietic cell transplantation in children with congenital severe T cell immunodeficiency
Immunologic Research (2009)